Literature DB >> 3177090

First-degree atrioventricular block in a young duodenal ulcer patient treated with a standard oral dose of ranitidine.

G Allegri1, K Pellegrini, G Dobrilla.   

Abstract

A 20-year-old male patient on oral treatment with ranitidine 300 mg/day in a single bedtime dose was admitted to hospital for a brief episode of syncope which had occurred 20 min earlier. All clinical, laboratory and instrumental examinations yielded negative findings, except for electrocardiographic evidence of first-degree atrioventricular block. Administration of atropine produced transient disappearance of the block, which disappeared altogether after discontinuing ranitidine treatment. Two separate rechallenges with ranitidine each produced recurrence of (asymptomatic) first-degree atrioventricular block at electrocardiographic examination, but oral treatment with cimetidine (400-800 mg/day) and famotidine (40-80 mg/day) induced no electrocardiographic abnormalities. The hypothesis that this patient may be abnormally susceptible to the cholinergic or cholinergic-like effect of ranitidine, a side effect unrelated to the drug's primary H2-blocking action, would appear to be consistent with evidence of an increased vagal tone of the atrioventricular node as revealed by atrial pacing. However, the ability of ranitidine to release histamine in man and the potential dysrhythmia-inducing effect of histamine should also be taken into consideration.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177090     DOI: 10.1007/bf02028277

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  17 in total

1.  Release of histamine by H2-receptor antagonists.

Authors:  W Lorenz; A Doenicke; W Dietz
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

2.  Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine.

Authors:  G Bertaccini; G Coruzzi
Journal:  Agents Actions       Date:  1982-04

3.  Ranitidine-induced bradycardia.

Authors:  E Camarri; E Chirone; G Fanteria; M Zocchi
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

4.  First-degree atrioventricular block induced by oral cimetidine.

Authors:  M Ishizaki; Y Yamada; T Kido; H Yamaya; K Nogawa; S Matsui; E Murakami
Journal:  Lancet       Date:  1987-01-24       Impact factor: 79.321

5.  Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject.

Authors:  W Lorenz; A Doenicke; B Schöning; C Ohmann; B Grote; E Neugebauer
Journal:  Klin Wochenschr       Date:  1982-09-01

6.  The response of heart rate and blood pressure and electrocardiographic changes induced by exercise in patients on oral ranitidine.

Authors:  S F Habba; E Fletcher; J S Doyle
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

7.  Esophageal pacing: a diagnostic and therapeutic tool.

Authors:  J J Gallagher; W M Smith; C R Kerr; J Kasell; L Cook; M Reiter; R Sterba; M Harte
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

8.  [Evaluation of various cardiovascular parameters during the intravenous administration of ranitidine].

Authors:  A Azzolini; R Gianrossi; S Livi; M C Nizzo; M Oliveri; P Mangini
Journal:  Boll Soc Ital Biol Sper       Date:  1982-07-30

9.  Cholinergic effects of cimetidine and ranitidine.

Authors:  L Re; M L Cingolani; C Concettoni; L Rossini
Journal:  Pharmacol Res Commun       Date:  1983-05

10.  Dysrhythmias caused by histamine release in guinea pig and human hearts.

Authors:  R Levi; A A Chenouda; J P Trzeciakowski; Z G Guo; L M Aaronson; R D Luskind; C H Lee; W A Gay; V A Subramanian; J C McCabe; J C Alexander
Journal:  Klin Wochenschr       Date:  1982-09-01
View more
  5 in total

1.  H2-blocker modulates heart rate variability.

Authors:  T Ooie; T Saikawa; M Hara; H Ono; M Seike; T Sakata
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 3.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

Review 4.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 5.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.